Cargando…
Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies
HIV/AIDS has become a worldwide pandemic. Before an effective HIV-1 vaccine eliciting broadly neutralizing monoclonal antibodies (bnmAbs) is fully developed, passive immunization for prevention and treatment of HIV-1 infection may alleviate the burden caused by the pandemic. Among HIV-1 infected ind...
Autores principales: | Sun, Zehua, Yan, Lixin, Tang, Jiansong, Qian, Qian, Lenberg, Jerica, Zhu, Dandan, Liu, Wan, Wu, Kao, Wang, Yilin, Lu, Shiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114535/ https://www.ncbi.nlm.nih.gov/pubmed/29051051 http://dx.doi.org/10.1016/j.virusres.2017.10.011 |
Ejemplares similares
-
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
por: Wang, Qian, et al.
Publicado: (2019) -
Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016) -
Tackling influenza with broadly neutralizing antibodies
por: Corti, Davide, et al.
Publicado: (2017) -
Contribution of rare mutational outcomes to broadly neutralizing antibodies: Rare features of unique anti-viral antibodies
por: Feng, Anqi, et al.
Publicado: (2022) -
HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)